Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Inoue · SciRah

Researcher profile · Semantic Scholar

E. Inoue

Share profile

E. Inoue — researcher profile on SciRah

h-index: 4
Works: 33
Citations: 110

Most-cited papers

Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)
Y. Takahashi, Y. Sunakawa, E. Inoue, R. Kawabata +16 more
2021Gastric Cancer35 citations Open access
Semantic Scholar
Genomic pathway of gut microbiome to predict efficacy of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08).
Y. Sunakawa, R. Matoba, E. Inoue, Y. Sakamoto +16 more
202123 citations
Semantic Scholar
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
H. Kawakami, Y. Sunakawa, E. Inoue, R. Matoba +19 more
2023European Journal of Cancer21 citations Open access
Semantic Scholar
DELIVER (JACCRO GC-08) trial: discover novel host-related immune-biomarkers for nivolumab in advanced gastric cancer.
Y. Sunakawa, E. Inoue, R. Matoba, H. Kawakami +5 more
2019Future Oncology11 citations
Semantic Scholar
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08)
Y. Sunakawa, Y. Sakamoto, R. Kawabata, A. Ishiguro +14 more
2024The Oncologist3 citations Open access
Semantic Scholar
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer.
C. Inagaki, R. Matoba, S. Yuki, M. Shiozawa +6 more
2023Future Oncology3 citations
Semantic Scholar
O1-4 Survival time of nivolumab treatment in advanced gastric cancer from real-world data of the DELIVER trial (JACCRO GC-08)
A. Ishiguro, E. Inoue, Y. Sakamoto, R. Kawabata +16 more
2021Annals of Oncology3 citations Open access
Semantic Scholar
An observational/translational study to conduct real-world evidence and develop biomarkers of fruquintinib for patients with metastatic colorectal cancer (mCRC): FruBLOOM trial (JACCRO CC-19).
Y. Sunakawa, Chiaki Inagaki, S. Yuki, K. Ouchi +6 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G
H. Arai, E. Inoue, K. Yamaguchi, N. Boku +11 more
2021Cancer Medicine2 citations Open access
Semantic Scholar
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study
D. Kotani, E. Inoue, T. Denda, Chiaki Inagaki +14 more
2026The Oncologist1 citations Open access
Semantic Scholar
SO-8 Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)
H. Kawakami, Y. Sunakawa, E. Inoue, R. Matoba +18 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
Host-related biomarkers including gut microbiome to predict toxicities of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08).
Y. Sunakawa, R. Matoba, T. Takayama, N. Okumura +16 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
O-13 Gut microbiome to predict survival time in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08)
Y. Sunakawa, R. Matoba, E. Inoue, Y. Sakamoto +18 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Clinical implication of using up both fluoropyrimidine (FU) and paclitaxel (PTX) in patients with severe peritoneal metastases (SPM) of gastric cancer (GC).
H. Arai, E. Inoue, K. Yamaguchi, N. Boku +11 more
20211 citations
Semantic Scholar
Survival analysis by tumor response from real-world data in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08).
Y. Kito, E. Inoue, Y. Akamaru, Masazumi Takahashi +16 more
20211 citations
Semantic Scholar
Interim analysis of an observational/translational study for nivolumab treatment in advanced gastric cancer: JACCRO GC-08 (DELIVER trial)
Y. Sunakawa, Y. Takahashi, E. Inoue, Y. Sakamoto +15 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
35P Association between tumor shrinkage and survival in BRAF-mutated metastatic colorectal cancer (mCRC) treated with encorafenib combination therapy: The BEETS trial (JACCRO CC-18)
Y. Sunakawa, D. Kotani, T. Denda, C. Inagaki +14 more
2026Annals of Oncology0 citations Open access
Semantic Scholar
111P Overall survival benefit of doublet versus triplet BRAF inhibitor–based therapy: Insights from the BEETS study (JACCRO CC-18)
C. Inagaki, R. Matoba, H. Lijuma, D. Kotani +16 more
2026Annals of Oncology0 citations
Semantic Scholar
606P Efficacy of capeOX plus nivolumab in patients with early relapsed HER2-negative gastric cancer: Results from the phase II JACCRO GC-11 (FirSTAR) trial
H. Arai, H. Takahashi, M. Tsuda, O. Muto +16 more
2026Annals of Oncology0 citations Open access
Semantic Scholar
Overall survival benefit of doublet versus triplet BRAF inhibitor–based therapy: Insights from the BEETS study (JACCRO CC-18).
Chiaki Inagaki, Ryo Matoba, E. Inoue, D. Kotani +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Encorafenib and cetuximab with/without binimetinib therapies for patients with BRAF -mutated metastatic colorectal cancer with prognostic factors: The BEETS trial (JACCRO CC-18).
Y. Sunakawa, E. Inoue, D. Kotani, T. Denda +14 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
20P Plasmatic biomarkers of BRAF inhibitor combination therapy for BRAF-mutated metastatic colorectal cancer: Insights from the BEETS trial (JACCRO CC-18)
C. Inagaki, R. Matoba, E. Inoue, D. Kotani +16 more
2025Annals of Oncology0 citations
Semantic Scholar
A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).
Hiroyuki Arai, E. Inoue, Masanori Terashima, E. Baba +7 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
482P Blood-based oxidative phosphorylation-related gene signature and their SNPs as novel prognostic biomarkers for gastric cancer patients treated with nivolumab
C. Inagaki, R. Matoba, H. Lijuma, J. Hihara +16 more
2024Annals of Oncology0 citations
Semantic Scholar
Survival analysis by tumor response of nivolumab treatment in previously treated advanced gastric cancer from the DELIVER trial (JACCRO GC-08).
Y. Sunakawa, Y. Sakamoto, R. Kawabata, A. Ishiguro +14 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
1547P SNP discovery based on transcriptome sequencing of whole blood RNA to find predictive biomarkers for nivolumab in gastric cancer
C. Inagaki, R. Matoba, H. Iijuma, J. Hihara +16 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
1224P Final analysis of clinical outcomes in the DELIVER trial: Observational study of nivolumab treatment in advanced gastric cancer (JACCRO GC-08)
Y. Sunakawa, E. Inoue, Y. Sakamoto, R. Kawabata +16 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
P-57 An observational/translational study of BRAF inhibitor combination therapy for BRAF-mutant metastatic colorectal cancer including biomarker research: BEETS trial (JACCRO CC-18)
Y. Sunakawa, C. Inagaki, S. Yuki, M. Shiozawa +5 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Factors associated with endoscopic treatment decisions for T1b or more deeply invading colorectal cancers
S. Nakatani, A. Katagiri, N. Suzuki, Kazuo Kikuchi +7 more
2021The Showa University Journal of Medical Sciences0 citations Open access
Semantic Scholar
LBA-4 Updated analysis of DELIVER trial (JACCRO GC-08): A large observational/translational study of nivolumab treatment in advanced gastric cancer
Y. Sunakawa, Y. Sakamoto, E. Inoue, R. Kawabata +18 more
20200 citations Open access
Semantic Scholar
Tumor response and growth rate of nivolumab treatment in advanced gastric cancer: Real-world data from a large observational/translational study, JACCRO GC-08 (deliver trial).
R. Kawabata, Y. Sakamoto, E. Inoue, A. Ishiguro +16 more
20200 citations
Semantic Scholar
A translational study to discover novel host-related immune-biomarkers for nivolumab (Nivo) in advanced gastric cancer (GC): JACCRO GC-08 (DELIVER trial)
Y. Sunakawa, K. Muro, T. Nakajima, H. Kawakami +5 more
2018Annals of Oncology0 citations Open access
Semantic Scholar
Phase 1/2a study of Mogamulizumab, an anti-CCR4 monoclonal antibody, in patients with HTLV-1-associated myelopathy (HAM/TSP)
Y. Yamano, T. Sato, Ariella Coler-Reilly, N. Yagishita +8 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Sunakawa×20
Invite
Y. Sunakawa — researcher profile on SciRah
W. Ichikawa×18
Invite
W. Ichikawa — researcher profile on SciRah
K. Muro×15
Invite
K. Muro — researcher profile on SciRah
M. Fujii×14
Invite
M. Fujii — researcher profile on SciRah

×13

Invite

Y. Kito — researcher profile on SciRah

A. Makiyama×13

Invite

A. Makiyama — researcher profile on SciRah

H. Kawakami×13

Invite

H. Kawakami — researcher profile on SciRah

Invite

Y. Akamaru — researcher profile on SciRah

H. Yabusaki×12

Invite

H. Yabusaki — researcher profile on SciRah

J. Matsuyama×12

Invite

J. Matsuyama — researcher profile on SciRah

T. Nakajima×12

Invite

T. Nakajima — researcher profile on SciRah

Invite

H. Yasui — researcher profile on SciRah